Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125820671 | 12582067 | 1 | I | 201407 | 20160704 | 20160722 | 20160722 | EXP | GB-MHRA-ADR 23544912 | GB-ACCORD-042247 | ACCORD | 52.00 | YR | F | Y | 0.00000 | 20160722 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125820671 | 12582067 | 1 | PS | LETROZOLE. | LETROZOLE | 1 | 90934 | ||||||||||||
| 125820671 | 12582067 | 2 | SS | IBANDRONIC ACID | IBANDRONIC ACID | 1 | 206058 | ||||||||||||
| 125820671 | 12582067 | 3 | SS | EXEMESTANE. | EXEMESTANE | 1 | Unknown | 44553 | |||||||||||
| 125820671 | 12582067 | 4 | SS | ZOMETA | ZOLEDRONIC ACID | 1 | Unknown | 0 | |||||||||||
| 125820671 | 12582067 | 5 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 0 | |||||||||||
| 125820671 | 12582067 | 6 | C | DENOSUMAB | DENOSUMAB | 1 | Unknown | 0 | |||||||||||
| 125820671 | 12582067 | 7 | C | MORPHINE | MORPHINE | 1 | Unknown | 0 | |||||||||||
| 125820671 | 12582067 | 8 | C | MAGNESIUM SALICYLATE | MAGNESIUM SALICYLATE | 1 | Unknown | 0 | |||||||||||
| 125820671 | 12582067 | 9 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | 0 | |||||||||||
| 125820671 | 12582067 | 10 | C | CARBIMAZOLE | CARBIMAZOLE | 1 | 0 | ||||||||||||
| 125820671 | 12582067 | 11 | C | DIAZEPAM. | DIAZEPAM | 1 | 0 | ||||||||||||
| 125820671 | 12582067 | 12 | C | MST CONTINUS | MORPHINE SULFATE | 1 | 0 | ||||||||||||
| 125820671 | 12582067 | 13 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125820671 | 12582067 | 14 | C | ZOPICLONE | ZOPICLONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125820671 | 12582067 | 1 | Product used for unknown indication |
| 125820671 | 12582067 | 2 | Product used for unknown indication |
| 125820671 | 12582067 | 3 | Product used for unknown indication |
| 125820671 | 12582067 | 4 | Metastases to bone |
| 125820671 | 12582067 | 5 | Product used for unknown indication |
| 125820671 | 12582067 | 6 | Product used for unknown indication |
| 125820671 | 12582067 | 7 | Product used for unknown indication |
| 125820671 | 12582067 | 8 | Product used for unknown indication |
| 125820671 | 12582067 | 9 | Product used for unknown indication |
| 125820671 | 12582067 | 10 | Product used for unknown indication |
| 125820671 | 12582067 | 11 | Product used for unknown indication |
| 125820671 | 12582067 | 12 | Product used for unknown indication |
| 125820671 | 12582067 | 13 | Product used for unknown indication |
| 125820671 | 12582067 | 14 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125820671 | 12582067 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125820671 | 12582067 | Breast cancer metastatic | |
| 125820671 | 12582067 | Disease progression | |
| 125820671 | 12582067 | Malignant neoplasm progression | |
| 125820671 | 12582067 | Metastases to lymph nodes |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |